Get started
Author

George A. Margaritopoulos

Observed names: G Margaritopoulos, G.A. Margaritopoulos, GEORGE MARGARITOPOULOS, George A Margaritopoulos, George Margaritopoulos
Observed institutions: National Health Service, University of Crete, Democritus University of Thrace, Guy's and St Thomas' NHS Foundation Trust, Aristotle University of Thessaloniki, Royal Brompton & Harefield NHS Foundation Trust, London North West Healthcare NHS Trust, Harefield Hospital, University of Manchester, Ruhrlandklinik, Manchester University NHS Foundation Trust, Royal Brompton Hospital, Ospedale G.B. Morgagni - L.Pierantoni, University Hospital of Heraklion, Wythenshawe Hospital, G. Papanikolaou General Hospital, Imperial College London, University of Duisburg-Essen
ORCID: 0000-0003-1418-8596
Observed ORCID: 0000-0003-1418-8596
OpenAlex ID: A5060595445
Interstitial lung disease
2014 · Katerina M. Antoniou, George A. Margaritopoulos, et al. · European Respiratory Review · 274
PDF
Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study
2020 · Thomas M. Drake, Annemarie B. Docherty, et al. · American Journal of Respiratory and Critical Care Medicine · 226
Predicting outcomes in rheumatoid arthritis related interstitial lung disease
2018 · Joseph Jacob, Nikhil Hirani, et al. · European Respiratory Journal · 179
PDF
Pivotal clinical dilemmas in collagen vascular diseases associated with interstitial lung involvement: Table 1—
2009 · K. M. Antoniou, G. Margaritopoulos, et al. · European Respiratory Journal · 162
PDF
NLRP3 inflammasome expression in idiopathic pulmonary fibrosis and rheumatoid lung
2016 · Ismini Lasithiotaki, Ioannis Giannarakis, et al. · European Respiratory Journal · 120
PDF
Comorbidities in interstitial lung diseases
2017 · George A. Margaritopoulos, Katerina M. Antoniou, et al. · European Respiratory Review · 112
PDF
Combined Pulmonary Fibrosis and Emphysema in Scleroderma‐Related Lung Disease Has a Major Confounding Effect on Lung Physiology and Screening for Pulmonary Hypertension
2015 · K. M. Antoniou, G. A. Margaritopoulos, et al. · Arthritis & Rheumatology · 110
PDF
Smoking and interstitial lung diseases
2015 · George A. Margaritopoulos, Eirini Vasarmidi, et al. · European Respiratory Review · 104
PDF
Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case–cohort study
2017 · Simon L.F. Walsh, Toby M. Maher, et al. · European Respiratory Journal · 99
PDF
Pirfenidone improves survival in IPF: results from a real-life study
2018 · George A. Margaritopoulos, Athina Trachalaki, et al. · BMC Pulmonary Medicine · 87
PDF
Pirfenidone in the treatment of idiopathic pulmonary fibrosis: an evidence-based review of its place in therapy
2016 · George Margaritopoulos, Eirini Vasarmidi, et al. · Core evidence · 81
PDF
Smoking‐related idiopathic interstitial pneumonia: A review
2015 · George A. Margaritopoulos, Sergio Harari, et al. · Respirology · 76
Idiopathic pulmonary fibrosis and sleep disorders: no longer strangers in the night
2015 · Sophia Schiza, Charalampos Mermigkis, et al. · European Respiratory Review · 70
PDF
Increased incidence of autoimmune markers in patients with combined pulmonary fibrosis and emphysema
2013 · Argyris Tzouvelekis, George Zacharis, et al. · BMC Pulmonary Medicine · 62
PDF
Upregulation of citrullination pathway: From Autoimmune to Idiopathic Lung Fibrosis
2017 · Katerina D. Samara, Athina Trachalaki, et al. · Respiratory Research · 59
PDF
Serum markers of pulmonary epithelial damage in systemic sclerosis‐associated interstitial lung disease and disease progression
2020 · Carmel J.W. Stock, Rachel K. Hoyles, et al. · Respirology · 58
PDF
Pleuroparenchymal fibroelastosis in systemic sclerosis: prevalence and prognostic impact
2020 · Martina Bonifazi, Nicola Sverzellati, et al. · European Respiratory Journal · 57
PDF
Interstitial Lung Disease in Systemic Sclerosis
2014 · George Margaritopoulos, Katerina Antoniou, et al. · Seminars in Respiratory and Critical Care Medicine · 55
Pharmacological treatment of idiopathic pulmonary fibrosis: from the past to the future
2013 · Katerina M. Antoniou, George A. Margaritopoulos, et al. · European Respiratory Review · 53
Recent advances in the pathogenesis and clinical evaluation of pulmonary fibrosis
2012 · G.A. Margaritopoulos, M. Romagnoli, et al. · European Respiratory Review · 52
PDF
Collagen 1a1 Expression by Airway Macrophages Increases In Fibrotic ILDs and Is Associated With FVC Decline and Increased Mortality
2021 · Eliza Tsitoura, Athina Trachalaki, et al. · Frontiers in Immunology · 44
PDF
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2023 · O Abani, A Abbas, et al. · The Lancet Diabetes & Endocrinology · 41
PDF
Smoking and Pulmonary Fibrosis: Novel Insights
2011 · Katerina D. Samara, George Margaritopoulos, et al. · Pulmonary Medicine · 41
PDF
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial
2024 · Saul N Faust, Richard Haynes, et al. · The Lancet Child & Adolescent Health · 39
PDF
Expression analysis of Akt and MAPK signaling pathways in lung tissue of patients with idiopathic pulmonary fibrosis (IPF)
2010 · Katerina M. Antoniou, George A. Margaritopoulos, et al. · Journal of Receptors and Signal Transduction · 38
Works count: 82
Citation count: 2,350
H-index: 24
I10-index: 39
Year
Topic
Type